Mon, Apr 21, 2014, 11:18 AM EDT - U.S. Markets close in 4 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • nomorelosses nomorelosses Mar 11, 2013 11:33 PM Flag

    A Doctor's point of view: part III

    This may very well be my last post here if the stage is set for Omontys issue is partially or wholly settled by this Thursday's CC. Of course some of you have read parts I & II of this series. I do, however, want to point out the followings (some of which is repeats):

    1- As previously mentioned I have been practicing medicine for a few decades and getting ready to hopefully retire in the near future. There is an old saying that there are no coincidences in medicine. Any doctor, nurse, pharmacist, etc involved in today's health care can tell you with 100% certainty that there is NO WAY IN THE WORLD that you could have over 25000 patients take any drug, by injection or otherwise, without any serious side effect and then suddenly in February, and after 11 months of usage, you have 3 deaths unless there were some new external factors introduced. Science of medicine while complicated it also involves some simple common sense facts and this is one of those facts. Omontys as manufactured prior to February could not have possibly caused those deaths. The culprit could be something went wrong on February batches or other medications were begun to be given at the same time as O beginning February that could have caused this or the culprit could be dialysis equipment malfunction or defect, or..., or...., or....BUT NOT OMONTYS AS MANUFACTURED UP UNTIL FEBRUARY AND AS USED BY THE FIRST 25000 PATIENTS.

    2-Omontys was and is well regarded by many physicians as once a month dosing allowed it to be administered in the nephrologist offices as well as some internists and family physicians and did not have to be necessarily coordinated with the dialysis centers. While currently most were given by these centers the trend was to move the injection to the clinics and no doubt once O is retuned to the market that trend will continue.

    3-The number of deaths....continued

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AFFY
0.61-0.02(-3.79%)10:49 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.